Hyalex Orthopaedics News
Featured
Featured Press
Initial Results of Hyalex Freestyle Knee Implant First-in-Human Clinical Studies to be Presented at the ISAKOS Congress 2025
- News, Press
Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant
- News, Press
Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors
- News, Press
Hyalex VP of R&D Mary Beth Schmidt presents at ICRS World Congress 2022
- News, Press
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
- News, Press
Hyalex Receives ISO 13485 Certification
- News, Press
Hyalex Giving Back: November 2021
- News
Mike Hawkins stepping in as interim President; Hyalex CEO & President, Mira Sahney, stepping down
- News
Hyalex receives FDA Breakthrough Device Designation for novel HYALEX® Cartilage System
- News
Hyalex Donates More Than 20 Prosthetic Hands with Generus and Hands of Gratitude
- News
Hyalex Named 2020 Emerging MedTech Company of the Year
- News
Hyalex Presents at 2020 Musculoskeletal New Ventures Conference
- News
Hyalex Presents at 2020 Materials Research Society
- News